Relevant clinical trials - 国人好像喜欢买补药不看重找信息

来源: 2014-07-29 09:25:28 [博客] [旧帖] [给我悄悄话] 本文已被阅读:
PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer
Condition: Stomach Neoplasms; Esophageal Neoplasms; Metastatic Gastric Cancer; Mutated PI3KCA Protein; Overexpressed HER2 Protein;
Interventions: Drug: AUY922; Drug: BYL719

Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery
Conditions: Adenocarcinoma of the Esophagus; Adenocarcinoma of the Gastroesophageal Junction; Diffuse Adenocarcinoma of the Stomach; Intestinal Adenocarcinoma of the Stomach; Mixed Adenocarcinoma of the Stomach; Recurrent Esophageal Cancer; Recurrent Gastric Cancer; Squamous Cell Carcinoma of the Esophagus; Stage IIIB Esophageal Cancer; Stage IIIB Gastric Cancer; Stage IIIC Esophageal Cancer; Stage IIIC Gastric Cancer; Stage IV Esophageal Cancer; Stage IV Gastric Cancer
Interventions: Drug: cyclodextrin-based polymer-camptothecin CRLX101; Other: Laboratory biomarker analysis; Other: Pharmacological studies

FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer
Condition: Advanced Gastric Cancer
Interventions: Drug: Pazopanib; Drug: 5-FU, Oxaliplatin, Leukovorin (FLO)

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors
Conditions: Dose Escalation; Safety; Preliminary Efficacy; Advanced Solid Tumors; Metastatic Breast Cancer; Advanced Pancreatic Adenocarcinoma; Metastatic Colorectal Cancer; Recurrent Glioblastoma Multiforme; Gastric Cancer; Gastroesophageal Junction Cancer; Triple Negative Metastatic Breast Cancer; Hormone Receptor Positive (ER+/PR+, and Her2-) Metastatic Breast Cancer
Interventions: Drug: LDE225; Drug: BKM120

Phase III Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer
Condition: Advanced or Metastatic Gastric Cancer
Interventions: Drug: apatinib; Drug: placebo

Dovitinib Plus Docetaxel in Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: Dovitinib and docetaxel